BIOMAT Database Logo BIOMAT Database Logo

[Griseofulvin in the therapy of scleroderma (preliminary note)]. 1967

M Pisani, and C Biondi, and F Mariotti

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006118 Griseofulvin An antifungal agent used in the treatment of TINEA infections. Fulvicin-U-F,Grifulvin V,Gris-PEG,Grisactin,Grisefuline,Fulvicin U F,FulvicinUF,Gris PEG,GrisPEG
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

M Pisani, and C Biondi, and F Mariotti
[Scleroderma therapy with penicillin G. Preliminary note].
January 1983, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
M Pisani, and C Biondi, and F Mariotti
[Therapy of scleroderma with griseofulvin (author's transl)].
August 1976, Ceskoslovenska dermatologie,
M Pisani, and C Biondi, and F Mariotti
[COMPARISON OF BLOOD GRISEOFULVIN LEVELS OBTAINED AFTER ADMINISTRATION OF ORDINARY AND MICRONIZED GRISEOFULVIN. PRELIMINARY NOTE].
January 1963, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
M Pisani, and C Biondi, and F Mariotti
[Griseofulvin in the treatment of circumscribed scleroderma].
January 1966, Dermatologica,
M Pisani, and C Biondi, and F Mariotti
Colchicine therapy in scleroderma. Preliminary results.
January 1979, Dermatologica,
M Pisani, and C Biondi, and F Mariotti
[SUCCESSFUL TREATMENT OF DIFFUSE SCLERODERMA WITH GRISEOFULVIN].
November 1963, Nederlands tijdschrift voor geneeskunde,
M Pisani, and C Biondi, and F Mariotti
[Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome].
January 1971, Reumatismo,
M Pisani, and C Biondi, and F Mariotti
A note on the solubility of griseofulvin.
October 1968, The Journal of pharmacy and pharmacology,
M Pisani, and C Biondi, and F Mariotti
Oral therapy with griseofulvin: preliminary report and review of the literature.
March 1960, The Ohio State medical journal,
M Pisani, and C Biondi, and F Mariotti
Use of griseofulvin in the therapy of tinea capitis in children; preliminary observations.
September 1959, Archives of dermatology,
Copied contents to your clipboard!